| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |